Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
12
Number of overlapping holdings
20.0%
% of XLV's 60 holdings also in PJP
40.0%
% of PJP's 30 holdings also in XLV
Overlap by Weight
Sector Drift (XLV minus PJP)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XLV |
Weight in PJP |
Overlap | |
|---|---|---|---|---|
 |
ABBVIE INC | 6.9% | 5.2% | 5.2% |
|
JOHNSON & JOHNSON | 7.5% | 5.1% | 5.1% |
|
ELI LILLY & CO | 12.3% | 4.7% | 4.7% |
|
ABBOTT LABORATORIES | 4.3% | 5.0% | 4.3% |
|
MERCK & CO. INC. | 4.3% | 5.0% | 4.3% |
Position Highlights (Non-Overlapping Exposures)
XLV Overweight Relative to PJP
|
UNITEDHEALTH GROUP INC | 9.0% |
|
ELI LILLY & CO | 7.6% |
|
THERMO FISHER SCIENTIFIC INC | 3.6% |
|
INTUITIVE SURGICAL INC | 3.3% |
|
BOSTON SCIENTIFIC CORP | 2.8% |
|
DANAHER CORP | 2.5% |
|
VERTEX PHARMACEUTICALS INC | 2.4% |
|
JOHNSON & JOHNSON | 2.4% |
|
STRYKER CORP | 2.4% |
 |
MEDTRONIC PLC | 2.1% |
XLV Underweight Relative to PJP
|
TARSUS PHARMACEUTICALS, INC. | -3.5% |
|
BIOSANTE PHARMACEUTICALS INC | -3.5% |
|
PERRIGO CO | -3.1% |
|
COLLEGIUM PHARMACEUTICAL, INC. | -2.9% |
|
INNOVIVA, INC. | -2.8% |
|
PACIRA PHARMACEUTICALS INC | -2.8% |
|
SUPERNUS PHARMACEUTICALS INC | -2.8% |
|
LIQUIDIA TECHNOLOGIES, INC. | -2.7% |
|
PRESTIGE BRANDS HOLDINGS INC | -2.7% |
|
AMNEAL PHARMACEUTICALS, INC. CLASS A | -2.7% |